Trials / Completed
CompletedNCT05967169
EFS of Bioabsorbable Implant for NSD
Early Feasibility Study of Bioabsorbable Polydioxanone Implant and Delivery Device for Correction of Cartilaginous Septal Deviation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Spirair, Inc · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Early feasibility study of bioabsorbable implant and delivery device for correction of septal deviation
Detailed description
To obtain safety, device performance, patient tolerability and effectiveness outcome data in participants with cartilaginous septal deviations undergoing placement of the Spirair Implant with the Spirair delivery device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nasal Septal Strap implantation | Correction of NSD with Nasal Septal Strap implant |
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2025-10-16
- Completion
- 2026-02-23
- First posted
- 2023-08-01
- Last updated
- 2026-03-30
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05967169. Inclusion in this directory is not an endorsement.